Therapeutic Effect of Oral Bisphosphonates on Choroidal Neovascularization in the Human Eye

Therapeutic Effect of Oral Bisphosphonates on Choroidal Neovascularization in the Human Eye

Purpose. Choroidal neovascularization (CNV) is often associated with age-related macular degeneration (AMD) and pathological myopia (PM). Bisphosphonates, the drug of choice to treat osteoporosis, have been recently reported to have anti-angiogenic effects. The purpose of this study is to investigat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shigeru Honda, Takayuki Nagai, Naoshi Kondo, Masahide Fukuda, Sentaro Kusuhara, Yasutomo Tsukahara, Akira Negi
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2010/206837
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Spontaneous Resolution of Subretinal Hemorrhage Secondary to Choroidal Osteoma Unassociated with Choroidal Neovascularization
by: Mehmet Talay Koylu, et al.
Published: (2014-01-01)

Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
by: Claudio Campa, et al.
Published: (2010-01-01)

Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
by: Somnath Chakraborty, et al.
Published: (2022-01-01)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01)

Management of Uveitis-Related Choroidal Neovascularization: From the Pathogenesis to the Therapy
by: Enzo D’Ambrosio, et al.
Published: (2014-01-01)

Correlation between Choroidal Neovascularization Shown by OCT Angiography and Choroidal Thickness in Patients with Chronic Central Serous Chorioretinopathy
by: Joanna Gołębiewska, et al.
Published: (2017-01-01)

Inflammatory Choroidal Neovascular Membranes: Clinical Profile, Treatment Effectiveness, and Visual Prognosis
by: Gonçalo Carrola, et al.
Published: (2021-01-01)

Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-β/Smad Signaling Pathway
by: Chuang Gao, et al.
Published: (2021-01-01)

Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
by: Jan Nemcansky, et al.
Published: (2019-01-01)

Analysis of Peripapillary and Macular Choroidal Thickness in Eyes with Pseudoexfoliative Glaucoma and Fellow Eyes
by: Fan Li, et al.
Published: (2020-01-01)

Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome
by: Dong Yoon Kim, et al.
Published: (2015-01-01)

Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment
by: Shira Hagbi-Levi, et al.
Published: (2019-01-01)

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
by: Belghmaidi Sarah, et al.
Published: (2016-01-01)

Management of Choroidal Neovascularization Associated with Optic Disc Melanocytoma with Intravitreal Aflibercept: A Case Report and Review of the Literature
by: Hany S. Hamza, et al.
Published: (2019-01-01)

Evolution of Choroidal Neovascularization due to Presumed Ocular Histoplasmosis Syndrome on Multimodal Imaging including Optical Coherence Tomography Angiography
by: T. Y. Alvin Liu, et al.
Published: (2018-01-01)

Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
by: Burak Erden, et al.
Published: (2019-01-01)

Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
by: Sónia Torres-Costa, et al.
Published: (2022-01-01)

Choroidal Thickness in Eyes with Band Atrophy of the Optic Nerve from Chiasmal Compression
by: Luiz Guilherme Marchesi Mello, et al.
Published: (2022-01-01)

Effect of Atropine Eye Drops on Choroidal Thinning Induced by Hyperopic Retinal Defocus
by: Samuel T.-H. Chiang, et al.
Published: (2018-01-01)

Two Cases of Periprosthetic Atypical Femoral Fractures in Patients on Long-Term Bisphosphonate Treatment
by: Takanori Miura, et al.
Published: (2019-01-01)

Macular Thickness, Foveal Volume, and Choroidal Thickness in Amblyopic Eyes and Their Relationships to the Treatment Outcome
by: Chun-Hsiu Liu, et al.
Published: (2018-01-01)

Choroidal and Retinal Thickness of Highly Myopic Eyes with Early Stage of Myopic Chorioretinopathy: Tessellation
by: Yanping Zhou, et al.
Published: (2018-01-01)

A New Rapidly Growing Dome-Shaped Choroidal Lesion in an Eye with Treated Retinoblastoma
by: Babak Masoomian, et al.
Published: (2021-01-01)

Outer Retinal Layers’ Thickness Changes in relation to Age and Choroidal Thickness in Normal Eyes
by: Mona Kamal Abdellatif, et al.
Published: (2019-01-01)

Effects of tropicamide and compound tropicamide eye drops on ocular biological parameters and choroid thickness in children
by: Mengyue Xu, et al.
Published: (2025-01-01)

Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
by: Bing Liu, et al.
Published: (2022-01-01)

Oral Squamous Cell Carcinoma Arising in a Patient after Hematopoietic Stem Cell Transplantation with Bisphosphonate-Related Osteonecrosis of the Jaws
by: Paolo G. Arduino, et al.
Published: (2015-01-01)

Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
by: Eder Alberto Sigua-Rodriguez, et al.
Published: (2014-01-01)

Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen
by: Alexandra Miere, et al.
Published: (2018-01-01)

The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization
by: Branislava Janic, et al.
Published: (2010-01-01)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
by: Zongyi Wang, et al.
Published: (2020-01-01)

Diurnal Choroidal Thickness Changes in Normal Eyes of Turkish People Measured by Spectral Domain Optical Coherence Tomography
by: Ozen Ayrancı Osmanbasoglu, et al.
Published: (2013-01-01)

Potential Use of Bisphosphonates in Invasive Extramammary Paget’s Disease: An Immunohistochemical Investigation
by: Taku Fujimura, et al.
Published: (2013-01-01)

Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw
by: Paolo Vescovi, et al.
Published: (2014-01-01)

Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype
by: Albina Tummolo, et al.
Published: (2013-01-01)

Multiple Myeloma and Bisphosphonate-Related Osteonecrosis of the Mandible Associated with Dental Implants
by: Luis Junquera, et al.
Published: (2011-01-01)

Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates
by: Wojciech P. Olszynski, et al.
Published: (2014-01-01)

Cytotoxic Activity of Bisphosphonic Derivatives Obtained by the Michaelis–Arbuzov or the Pudovik Reaction
by: Zsuzsanna Szalai, et al.
Published: (2025-01-01)

Effect of bisphosphonate on bone microstructure, mechanical strength in osteoporotic rats by ovariectomy
by: Yuzhu Wang, et al.
Published: (2024-09-01)

Synthesis and Antitumor Activity of a GSH Inert Bisphosphonate Platinum (II) Complex
by: Lu Ma, et al.
Published: (2022-01-01)